$40+ Billion Facial Injectables Market Outlook, 2037: Botulinum Toxin Type A Products, Particularly in the U.S., Will Generate the Most Revenue

Dublin, Oct. 14, 2024 (GLOBE NEWSWIRE) — The “Global Facial Injectables Market Outlook 2037” report has been added to ResearchAndMarkets.com’s offering.

The global market for facial injectables is poised to rise at a CAGR of 10.86% over the forecast period, i.e., 2025-2037. This growth of the market is set to be dominated by a growing geriatric population along with growing consciousness among people regarding beauty. Furthermore, the market is also projected to rise on account of the rising trend of minimally invasive surgeries and the surging advancement of facial injectables. The market is estimated to capture a revenue of about USD 40 billion by the end of 2037, up from a revenue of more than USD 10 billion in the year 2024.

The global market for facial injectables is segmented into numerous segments including product, application, and end-user. By product, the market for facial injectables is further segmented into collagen, hyaluronic acid [HA], botulinum toxin type A, calcium hydroxylapatite [CaHA], and polymer fillers. Amongst these, the botulinum toxin type A segment is predicted to generate the largest market revenue of USD 20 billion by the end of 2037. This could be owing to its ability to prevent repetitive muscular spasms.

On the basis of region, the global facial injectables market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North America market is projected to gather the highest market revenue of over USD 14 billion by the end of 2037, up from a revenue of close to USD 3 billion in the year 2024. This growth of the market in this region is poised to be encouraged by growing spending on cosmetics.

Some of the prominent industry leaders in the global facial injectables market that are included in the report are:

  • AbbVie Inc.
  • Medytox
  • Galderma
  • Sinclair Ltd.
  • Merz Pharma
  • SciVision Biotech Inc.
  • NovaCutis Inc.
  • Bioplus Co. Ltd.
  • Suneva Medical
  • Ipsen Pharma

Key Topics Covered

1 An Outline of the Facial Injectables Market
2 Assumptions & Abbreviations
3 Research Methodology & Approach
4 Summary of the Report for Key Decision Makers
5 Market Opportunities
6 Market Dynamics
7 Major Roadblocks
8 Government Regulation: How they would aid business?
9 Analysis on Ongoing Technological Advancements
10 Industry Risk Analysis
11 Industry Pricing Benchmarking & Analysis
12 SWOT Analysis on the Facial Injectables Market
13 Industry Growth Outlook
14 Regional Demand Analysis
15 Competitive Positioning: Key Players
16 Competitive Model : A Detailed Inside View for Investors
17 Global Facial Injectables Market Outlook
18 North America Facial Injectables Market Outlook
19 Europe Facial Injectables Market Outlook
20 Asia Pacific excluding Japan Facial Injectables Market Outlook
21 Japan Facial Injectables Market Outlook
22 Latin America Facial Injectables Market Outlook
23 Middle East & Africa Facial Injectables Market Outlook

For more information about this report visit https://www.researchandmarkets.com/r/r5et24

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: 
CONTACT: ResearchAndMarkets.com 
         Laura Wood,Senior Press Manager 
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470 
         For U.S./ CAN Toll Free Call 1-800-526-8630 
         For GMT Office Hours Call +353-1-416-8900 

spot_img

More from this stream

Recomended